Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.5M Buy
+72,700
New +$5.47M ﹤0.01% 3604
2018
Q1
Sell
-13,300
Closed -$569K 6095
2017
Q4
$569K Sell
13,300
-500
-4% -$19.9K ﹤0.01% 4727
2017
Q3
$506K Buy
13,800
+8,000
+138% +$323K ﹤0.01% 5076
2017
Q2
$263K Sell
5,800
-1,400
-19% -$61.8K ﹤0.01% 5604
2017
Q1
$306K Sell
7,200
-11,800
-62% -$481K ﹤0.01% 5447
2016
Q4
$762K Buy
19,000
+10,500
+124% +$405K ﹤0.01% 4692
2016
Q3
$330K Buy
8,500
+1,400
+20% +$52.9K ﹤0.01% 5402
2016
Q2
$246K Buy
7,100
+400
+6% +$13.9K ﹤0.01% 5518
2016
Q1
$231K Sell
6,700
-67,000
-91% -$2.34M ﹤0.01% 5492
2015
Q4
$2.85M Sell
73,700
-108,800
-60% -$4.23M ﹤0.01% 3321
2015
Q3
$7.14M Buy
182,500
+151,700
+493% +$6.02M ﹤0.01% 2556
2015
Q2
$1.17M Buy
30,800
+15,100
+96% +$529K ﹤0.01% 4395
2015
Q1
$518K Buy
15,700
+10,400
+196% +$319K ﹤0.01% 5090
2014
Q4
$142K Sell
5,300
-1,000
-16% -$25.8K ﹤0.01% 6395
2014
Q3
$153K Sell
6,300
-1,100
-15% -$27.8K ﹤0.01% 6359
2014
Q2
$188K Sell
7,400
-50,600
-87% -$1.18M ﹤0.01% 6243
2014
Q1
$1.25M Sell
58,000
-162,100
-74% -$3.5M ﹤0.01% 4450
2013
Q4
$4.92M Sell
220,100
-478,900
-69% -$10.6M ﹤0.01% 3097
2013
Q3
$14.4M Buy
699,000
+160,200
+30% +$3.41M 0.01% 1892
2013
Q2
$10.4M Buy
+538,800
New +$11.3M ﹤0.01% 2050

Other funds holding HOLX

Goldman Sachs's HOLX Position: Q1 2026 in Review

Goldman Sachs increased its Hologic (HOLX) stake by 131% in Q1 2026, buying an estimated $99M and bringing the position to 2,322,673 shares worth $176M. The position accounts for 0.02% of the portfolio, ranked #731.

Goldman Sachs first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $253M in Q1 2021. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Goldman Sachs held 2,322,673 shares of Hologic worth $176M as of Q1 2026.
  • Goldman Sachs bought 1,316,484 Hologic shares in Q1 2026, an estimated $99M.
  • Hologic made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #731 holding.
  • Goldman Sachs first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Hologic position peaked at $253M in Q1 2021.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.